MOFILET 500MG TABLET

Mofilet 500 mg  tablets are an immune suppressant with an active ingredient named Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is used to stop organ rejection in patients who have received the organs of a donor (such as heart, kidney, and liver transplantation). It is usually prescribed as part of a treatment combination that includes other immunosuppressive medicines.
This medication is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It should not be used for pregnant women unless there are no other alternatives and the possible advantages outweigh the risks. Women of childbearing age should take effective contraceptives while taking this tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered when a person is taking Mofilet 500 mg Tablet because of the decreased vaccine effectiveness and risk of contracting infection. Patients taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug has been completely removed from the body before giving blood.
It is recommended not to take this drug in case you have an allergy to the drug or other ingredients. Inform your doctor about heart or liver disease before beginning treatment. Since this medication weakens the body’s immune defenses, it increases the risk of developing skin cancer. People should take steps to minimize their exposure to sun and the ultraviolet (UV) ultraviolet (UV) light. Consult your physician immediately when you experience any bleeding on your skin or the face, fever, unprovoked tiredness, dizziness or discoloration of the skin or eyes vision impairment, decreased urinary output, or seizures following this medication. Mofilet, 500 mg Tablet, is an anti-inflammatory medication. It could affect the baby’s developing immune system and should not be used during breastfeeding. In certain instances, alternatives to drugs that have better safety profiles while breastfeeding might be thought of as.